Inclusion complexes of ketoconazole with beta-cyclodextrin: Physicochemical characterization and in vitro dissolution behaviour of its vaginal suppositories

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 70, Issue 3-4, 2011, Pages 437-445

  Demirel, Müzeyyen ^a   Yurtdaş, Gülsel ^a   Genç, Lütfi ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Cyclodextrin; Inclusion complexes; Ketoconazole; Phase solubility studies; Vaginal suppositories

Indexed keywords

EID: 80051781966     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9922-1     Document Type: Conference Paper

References (36)

1. Sweetman, S.C.; Blake, P.S.; Brayfield, A.; McGlashan, J.M.; Neathercoat, G.C.; Parsons, A.V.: Martindale: The Complete Drug References, 36th edn. pp. 539-540. Pharmaceutical Press, Gurnee (2009)
2. Richardson, M.D.; Warnock, D.W.: Fungal infection-diagnosis and management. Blackwell Scientific Publications, London (1993)
3. Connors, R.D.; Elder, E.J.: Using a portfolio of particle growth technologies to enable delivery of drugs with poor water solubility. Solubilization solutions. Drug Deliv. Technol. 4(8), (2004). http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=&nm=&type= Publishing&mod=Publications%3A%3AArticle&mid= 8F3A7027421841978F18BE895F87F791&tier=4&id= 51EA11B6268048338C15D4DD2D00C55C. Accessed 01 Sept 2010
4. E Gallia E Nicolaides D Horter R Lobenberg C Reppas JB Dressman 1998 Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs Pharm. Res. 15 698 705 10.1023/A:1011910801212 (Pubitemid 28275645)
5. Shrum, J.P.; Milikan, L.E.: Oral antifungal therapy. In: Milikan, L.E. (ed.) Drug therapy in dermatology, pp. 79-102. Markel Decker Inc, New York (2000)
6. ATM Serajuddin 1999 Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs J. Pharm. Sci. 88 10 1058 1066 10.1021/js980403l 1:CAS:528:DyaK1MXltl2jtbk%3D (Pubitemid 29480600)
7. Nash, R.A.: Cyclodextrins. In: Kibbe, A.H. (ed.) Handbook of pharmaceutical excipients, 3rd edn.; pp.165-168. Published by the American Pharmaceutical Association, Pharmaceutical Press, Washington (2000)
8. T Loftsson 1999 Pharmaceutical application of β-cyclodextrin Pharm. Techn. 85 1017 1025
9. MT Esclusa-Díaz M Gayo-Otero MB Pérez-Marcos JL Vila-Jato JJ Torres-Labandeira 1996 Preparation and evaluation of ketoconazole-β- cyclodextrin multicomponent complexes Int. J. Pharm. 142 183 187 10.1016/0378-5173(96)04666-2 (Pubitemid 26354644)
10. GA Shabir 2003 Validation of high-performance liquid chromatography methods for pharmaceutical analysis understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the international conference on harmonization J. Chromatogr. A 987 57 66 10.1016/S0021-9673(02)01536-4 1:CAS:528:DC%2BD3sXptlyquw%3D%3D (Pubitemid 36140080)
11. USP 31 (The United States Pharmacopeia), 26th edn.; pp. 2488-2490. The United States Pharmacopeial convention, Rockville (2008)
12. T Higuchi KA Connors 1965 Phase solubility techniques Adv. Anal. Chem. Instrum. 4 117 210 1:CAS:528:DyaF2MXktlGitrg%3D
13. MV Gaspar de Araujo EKB Vieira GS Lázaro LS Conegero LEA Almeida LS Barreto N Bezerra da Costa Jr IF Gimenez 2008 Sulfadiazine/hydroxypropyl- β-cyclodextrin host-guest system: Characterization, phase-solubility and molecular modeling Bioorg. Med. Chem 16 5788 5794 10.1016/j.bmc.2008.03.057 1:CAS:528:DC%2BD1cXmsVamsLo%3D (Pubitemid 351699276)
14. AH Al-Marzouqi HM Elwy I Shehadi A Adem 2009 Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques J. Pharm. Biopharm. 49 227 233 1:CAS:528:DC%2BD1MXhs1amu7k%3D
15. L Wang X Tang 2008 A novel KZ bioadhesive effervescent tablet for vaginal delivery: Design, in vitro and in vivo evaluation Int. J. Pharm. 350 181 187 10.1016/j.ijpharm.2007.08.042 1:CAS:528:DC%2BD1cXhtlGntb4%3D
16. HD Owen DF Katz 1999 A vaginal fluid simulant Contraception 59 91 95 10.1016/S0010-7824(99)00010-4 1:CAS:528:DyaK1MXjvVeju70%3D (Pubitemid 29244754)
17. MA Alam FJ Ahmad ZI Khan KR Khar M Ali 2007 Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections AAPS Pharm. Sci. Tech. 8 4 E1 E8 10.1208/pt0804109
18. N Li Y-H Zhang X-L Xiong Z-G Li X-H Jin Y-N Wu 2005 Study of the physicochemical properties of trimethoprim with β-cyclodextrin in solution J. Pharm. Biomed. Anal. 38 2 370 374 10.1016/j.jpba.2005.01.014 1:CAS:528:DC%2BD2MXltVegtL4%3D (Pubitemid 40733169)
19. T Loftsson D Duchéne 2007 Cyclodextrins and their pharmaceutical applications Int. J. Pharm. 329 1 11 10.1016/j.ijpharm.2006.10.044 1:CAS:528:DC%2BD28XhtlCmtLrF (Pubitemid 44937538)
20. S-H Lin Y-H Kao 1989 Solid particulates of drug-β-cyclodextrin inclusion complexes directly prepared by a spray-drying technique Int. J. Pharm. 56 249 259 10.1016/0378-5173(89)90022-7 1:CAS:528:DyaK3cXotl2rsA%3D%3D (Pubitemid 20004828)
21. AMI Denadai MM Santoro MTP Lopes A Chenna FB De Sousa GM Avelar MRT Gomes F Guzman CE Salas RD Sinisterra 2006 A supramolecular complex between proteinases and beta-cyclodextrin that preserves enzymatic activity Biodrugs 20 283 291 10.2165/00063030-200620050-00004 1:CAS:528:DC%2BD28XhtlSntbnP (Pubitemid 44556052)
22. C Jianbin C Liang X Hao M Dongpin 2002 Preparation and study on the inclusion complex of ciprofloxacin with β-cyclodextrin Spectrochim. Acta A-M 58 2809 2815 10.1016/S1386-1425(02)00078-1 (Pubitemid 35384767)
23. Y Yazan M Sumnu 1994 Improvement in the dissolution properties of theophylline with β-cyclodextrin S.T.P. Pharm. Sci. 4 2 128 132 1:CAS:528:DyaK2cXkvFWntLo%3D (Pubitemid 24117603)
24. F Taneri T Güneri Z Aigner O Berkesi M Kata 2003 Thermoanalytical studies on complexes of KZ with cyclodextrin derivatives J. Therm. Anal. Calorim. 74 769 777 10.1023/B:JTAN.0000011009.46113.01 1:CAS:528: DC%2BD2cXhtFOrsw%3D%3D
25. M Wulff M Aldén 1999 Solid state studies of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method Eur. J. Pharm. Sci. 8 269 281 10.1016/S0928-0987(99)00020-2 1:CAS:528:DyaK1MXks1CkurY%3D (Pubitemid 29325019)
26. M Demirel G Büyükköroǧlu BS Kalava Y Yazan 2006 Enhancement in dissolution pattern of piribedil by molecular encapsulation with β-cyclodextrin Methods Find Exp.Clin. Pharmacol. 28 2 83 88 10.1358/mf.2006.28.2.977838 1:CAS:528:DC%2BD28XmsVGlsrg%3D
27. 1H NMR and ROESY experiments Eur. J. Pharm. Sci. 18 285 296 10.1016/S0928-0987(03)00025-3 1:CAS:528:DC%2BD3sXivFCqtb4%3D (Pubitemid 36407688)
28. L Riberio RA Carvalho DC Ferreira FJB Veiga 2005 Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies Eur. J. Pharm. Sci. 24 1 13 10.1016/j.ejps.2004.09.003 (Pubitemid 40051282)
29. CM Fernandes MT Vieira FJB Veiga 2002 Physicochemical characterization and in vitro dissolution behavior of nicardipin cyclodextrins inclusion compounds Eur. J. Pharm. Sci. 15 79 88 10.1016/S0928-0987(01)00208-1 1:CAS:528:DC%2BD38Xms1Glsg%3D%3D (Pubitemid 34136971)
30. AH Al-Marzouqi A Solieman I Shehadi A Adem 2008 Influence of the preparation method on the physicochemical properties of econazole-β- cyclodextrin complexes J. Incl. Phenom. Macrocycl. Chem. 60 85 93 10.1007/s10847-007-9356-6 1:CAS:528:DC%2BD1cXoslWrsw%3D%3D
31. SM Badr-Eldin SA Elkheshen MM Ghorab 2008 Inclusion complexes of tadalafil with natural and chemically modified β-cyclodextrins. I: Preparation and in vitro evaluation Eur. J. Pharm. Biopharm. 70 819 827 10.1016/j.ejpb.2008.06.024 1:CAS:528:DC%2BD1cXhtlagsL7F
32. JY Legendre I Rault A Petit W Luijten I Demuynck S Horvath YM Ginot A Cuine 1995 Effects of β-cyclodextrins on skin: Implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977 Eur. J. Pharm. Sci. 3 311 322 10.1016/0928-0987(95)00020-0 1:CAS:528: DyaK2MXpvVyqtbo%3D
33. B Gordon LJ Schep MY Tan 1999 Improvement of the in vitro dissolution of praziquantel by complexation with, α β and γ-cyclodextrins Int. J. Pharm. 179 65 71 10.1016/S0378-5173(98)00382-2 (Pubitemid 29115061)
34. A Rasheed ACK Kumar VVNSS Sravanthi 2008 Cyclodextrins as drug carrier molecule: A review Sci. Pharm. 76 567 598 10.3797/scipharm.0808-05 1:CAS:528:DC%2BD1MXlslKmt7s%3D
35. RB Gandhi AH Karara 1988 Characterization, dissolution and diffusion properties of tolbutamide-β-cyclodextrin complex system Drug Dev. Ind. Pharm. 14 657 682 10.3109/03639048809151892 1:CAS:528:DyaL1cXks1Wgt78%3D
36. V Londhe M Nagarsenker 1999 Comparision between hydroxypropyl-β -cyclodextrin and polyvinyl pyrolidine as carriers for carbamazepine solid dispersions Indian J. Pharm. Sci. 61 237 240 1:CAS:528:DC%2BD3cXivFOgs74%3D